Valuation: Old API Wind-down Ltd.

Market Cap 87.35K 76.66K 71.39K 65.66K 123K 8.35M 125K 847K 331K 4.14M 328K 321K 14.3M P/E 2016
-2.53x
P/E 2017 -0.75x
Enterprise Value 246M 216M 201M 185M 346M 23.48B 352M 2.38B 933M 11.64B 923M 903M 40.23B EV / Sales 2016
9.18x
EV / Sales 2017 3.22x
Free-Float
100%
Yield 2016 *
-
Yield 2017 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 0
+1.87%+3.81%+51.00%+166.15% 1,068B
+0.65%+7.11%+61.48%+53.84% 641B
+3.33%+3.62%+40.76%+75.92% 454B
+2.17%+10.22%+41.17%+36.56% 351B
+1.46%+3.87%+39.70%+44.49% 299B
+0.40%+3.59%+19.93%+17.02% 266B
+2.73%+3.50%-25.66%-36.53% 220B
+3.95%+6.78%+29.80%+65.44% 203B
+2.55%+2.69%+18.37%+74.07% 162B
Average +1.96%+2.48%+30.73%+55.22% 366.33B
Weighted average by Cap. +1.96%+2.85%+40.23%+80.34%

Financials

2016 2017
Net sales 54.27M 47.63M 44.35M 40.79M 76.47M 5.18B 77.78M 526M 206M 2.57B 204M 199M 8.88B 106M 92.98M 86.58M 79.64M 149M 10.12B 152M 1.03B 402M 5.02B 398M 389M 17.34B
Net income -103M -90.37M -84.16M -77.4M -145M -9.84B -148M -998M -391M -4.88B -387M -378M -16.86B -125M -110M -102M -94.11M -176M -11.96B -179M -1.21B -475M -5.93B -470M -460M -20.5B
Net Debt 209M 184M 171M 157M 295M 20.01B 300M 2.03B 795M 9.93B 786M 770M 34.29B 246M 216M 201M 185M 346M 23.47B 352M 2.38B 932M 11.64B 922M 902M 40.21B
Logo Old API Wind-down Ltd.
Old API Wind-Down Ltd, formerly Aralez Pharmaceuticals Inc., is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company's products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G. Its development products include YOSPRALA and Bilastine. Fibricor (fenofibric acid) is indicated as a complementary therapy along with diet for the treatment of hypertriglyceridemia, and as a complementary therapy along with diet to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), triglycerides (TG) and apolipoprotein B (Apo B). Fibricor is also used to increase high-density lipoprotein (HDL) cholesterol (HDL-C) in patients with hypercholesterolemia or mixed dyslipidemia. Cambia (diclofenac potassium for oral solution) is a non-steroidal anti-inflammatory drug (NSAID).
Employees
-
  1. Stock Market
  2. Stocks
  3. ARLZQ Stock